Official Title
COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined
Phase
Phase 4Lead Sponsor
University of OsloStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Rupture of Anterior Cruciate LigamentIntervention/Treatment
urea parecoxib valdecoxib etoricoxib ...Study Participants
93Recent studies on molar surgery have shown that a combination of a glucocorticoid and NSAID or COX-2 selective inhibitor gives better pain relief than either of the drugs used separately. The investigators group has also shown that adding dexamethasone on top of a regimen of paracetamol, NSAID and local anesthesia resulted in 45% painfree patients at rest after ambulatory breast cancer surgery.
The goal of this study is to test the NSAID + glucocorticoid concept in ACl repair. The investigators want to evaluate whether a selective COX-2 selective inhibitor or a glucocorticoid or a combination of both drugs, as part of a multimodal analgesic regime, can provide improved pain relief and shorter hospital stay in patients undergoing outpatient ACL surgery.
40 mg parecoxib (Dynastat, Pfizer®) one hour before surgery and 40 mg valdecoxib (prodrug of parecoxib, Bextra, Pfizer®)were given 8 hour after surgery. After retraction of parecoxib from the market: Etoricoxib (Arcoxia, MSD) 120 mg given one hour before surgery
8 mg IV
combination of both drugs
40 mg parecoxib (Dynastat, Pfizer®) one hour before surgery and 40 mg valdecoxib (prodrug of parecoxib, Bextra, Pfizer®)were given 8 hour after surgery. After retraction of parecoxib from the market: Etoricoxib (Arcoxia, MSD) 120 mg given one hour before surgery
combination of coxib AND dexamethasone
Inclusion Criteria: Arthroscopic reconstruction of the anterior crucial ligament (ACL) At least 18 years old ASA I + II Exclusion Criteria: Known renal impairment Liver failure and/-or an asthmatic condition Pregnancy Breast feeding